Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 442 Rectal Neoplasms 209 Colonic Neoplasms 202 Pancreatic Neoplasms 133 Stomach Neoplasms 117 Neoplasm Metastasis 97 Neoplasms 64 Esophageal Neoplasms 57 Precursor Cell Lymphoblastic Leukemia-Lymphoma 51 Lymphoma 49 Leukemia 41 Carcinoma, Hepatocellular 41 Adenocarcinoma Of Esophagus 37 Burkitt Lymphoma 34 Adenocarcinoma 29 Cholangiocarcinoma 27 Biliary Tract Neoplasms 23 Carcinoma, Non-Small-Cell Lung 21 Gastrointestinal Neoplasms 20 Gallbladder Neoplasms 20 Lymphoma, Non-Hodgkin 19 Esophageal Squamous Cell Carcinoma 15 Osteosarcoma 14 Liver Neoplasms 14 Leukemia, Biphenotypic, Acute 14 Bile Duct Neoplasms 14 Unspecified Adult Solid Tumor, Protocol Specific 13 Lymphoma, Large B-Cell, Diffuse 13 Ovarian Neoplasms 12 Leukemia, Myeloid, Acute 12

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ampullary Adenocarcinoma × Leucovorin × Clear all

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡